Upgrade your clinical operations with real-time AI
Biocogniv has raised $5.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in October 2023.
Biocogniv's investors include National Science Foundation, Y Combinator, 1984 Ventures, Promus Ventures, Breyer Capital.
Biocogniv is headquartered in Burlington, United States.
Upgrade your clinical operations with real-time AI
Biocogniv is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Biocogniv — Funding & Investors." VCBacked, October 19, 2023, https://www.vcbacked.co/company/biocogniv. Accessed July 20, 2026.
VCBacked. (2023). Biocogniv — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/biocogniv
{{cite web |title=Biocogniv — Funding & Investors |url=https://www.vcbacked.co/company/biocogniv |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated